Works by Nabors, L. Burt


Results: 46
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    The role of Src family kinases in growth and migration of glioma stem cells.

    Published in:
    International Journal of Oncology, 2014, v. 45, n. 1, p. 302, doi. 10.3892/ijo.2014.2432
    By:
    • XIAOSI HAN;
    • WENBIN ZHANG;
    • XIUHUA YANG;
    • WHEELER, CRYSTAL G.;
    • LANGFORD, CATHERINE P.;
    • LU WU;
    • FILIPPOVA, NATALIA;
    • FRIEDMAN, GREGORY K.;
    • QIANG DING;
    • FATHALLAH-SHAYKH, HASSAN M.;
    • YANCEY GILLESPIE2, G.;
    • BURT NABORS, L.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 10, p. 1422, doi. 10.1093/neuonc/noaa142
    By:
    • Grossman, Stuart A;
    • Romo, Carlos G;
    • Rudek, Michelle A;
    • Supko, Jeffrey;
    • Fisher, Joy;
    • Nabors, L Burt;
    • Wen, Patrick Y;
    • Peereboom, David M;
    • Ellingson, Benjamin M;
    • Elmquist, William;
    • Barker, Fred G;
    • Kamson, David;
    • Sarkaria, Jann N;
    • Timmer, William;
    • Bindra, Ranjit S;
    • Ye, Xiaobu
    Publication type:
    Article
    17
    18

    The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 12, p. 1498, doi. 10.1093/neuonc/noz119
    By:
    • Horbinski, Craig;
    • Ligon, Keith L;
    • Brastianos, Priscilla;
    • Huse, Jason T;
    • Venere, Monica;
    • Chang, Susan;
    • Buckner, Jan;
    • Cloughesy, Timothy;
    • Jenkins, Robert B;
    • Giannini, Caterina;
    • Stupp, Roger;
    • Nabors, L Burt;
    • Wen, Patrick Y;
    • Aldape, Kenneth J;
    • Lukas, Rimas V;
    • Galanis, Evanthia;
    • Eberhart, Charles G;
    • Brat, Daniel J;
    • Sarkaria, Jann N
    Publication type:
    Article
    19
    20
    21
    22
    23

    ATIM-06. PHASE 2 TRIAL OF SL-701 + BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED GLIOBLASTOMA (GBM) MEETS PRIMARY ENDPOINT OF OS-12, WITH PRELIMINARY CORRELATION BETWEEN LONG-TERM SURVIVAL AND TARGET-SPECIFIC CD8+ T CELL IMMUNE RESPONSE.

    Published in:
    Neuro-Oncology, 2018, v. 20, p. vi2, doi. 10.1093/neuonc/noy148.003
    By:
    • Peereboom, David;
    • Nabors, L Burt;
    • Kumthekar, Priya;
    • Badruddoja, Michael;
    • Fink, Karen;
    • Lieberman, Frank;
    • Phuphanich, Surasak;
    • Dunbar, Erin;
    • Walbert, Tobias;
    • Schiff, David
    Publication type:
    Article
    24
    25

    Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 8, p. 1119, doi. 10.1093/neuonc/nox025
    By:
    • Blumenthal, Deborah T.;
    • Gorlia, Thierry;
    • Gilbert, Mark R.;
    • Kim, Michelle M.;
    • Nabors, L. Burt;
    • Mason, Warren P.;
    • Hegi, Monika E.;
    • Zhang, Peixin;
    • Golfinopoulos, Vassilis;
    • Perry, James R.;
    • Nam, Do Hyun;
    • Erridge, Sara C.;
    • Corn, Benjamin W.;
    • Mirimanoff, René O.;
    • Brown, Paul D.;
    • Baumert, Brigitta G.;
    • Mehta, Minesh P.;
    • van den Bent, Martin J.;
    • Reardon, David A.;
    • Weller, Michael
    Publication type:
    Article
    26
    27
    28

    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

    Published in:
    Neuro-Oncology, 2015, v. 17, n. 5, p. 708, doi. 10.1093/neuonc/nou356
    By:
    • Nabors, L. Burt;
    • Fink, Karen L.;
    • Mikkelsen, Tom;
    • Grujicic, Danica;
    • Tarnawski, Rafal;
    • Do Hyun Nam;
    • Mazurkiewicz, Maria;
    • Salacz, Michael;
    • Ashby, Lynn;
    • Zagonel, Vittorina;
    • Depenni, Roberta;
    • Perry, James R.;
    • Hicking, Christine;
    • Picard, Martin;
    • Hegi, Monika E.;
    • Lhermitte, Benoit;
    • Reardon, David A.
    Publication type:
    Article
    29
    30

    Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.

    Published in:
    International Journal of Cancer, 2020, v. 146, n. 3, p. 739, doi. 10.1002/ijc.32318
    By:
    • Ostrom, Quinn T.;
    • Egan, Kathleen M.;
    • Nabors, L. Burt;
    • Gerke, Travis;
    • Thompson, Reid C.;
    • Olson, Jeffrey J.;
    • LaRocca, Renato;
    • Chowdhary, Sajeel;
    • Eckel‐Passow, Jeanette E.;
    • Armstrong, Georgina;
    • Wiencke, John K.;
    • Bernstein, Jonine L.;
    • Claus, Elizabeth B.;
    • Il'yasova, Dora;
    • Johansen, Christoffer;
    • Lachance, Daniel H.;
    • Lai, Rose K.;
    • Merrell, Ryan T.;
    • Olson, Sara H.;
    • Sadetzki, Siegal
    Publication type:
    Article
    31
    32
    33

    Longitudinal brain volumetrics in glioma survivors.

    Published in:
    Journal of Neurosurgery, 2024, v. 141, n. 3, p. 634, doi. 10.3171/2024.1.JNS231980
    By:
    • McDonald, Andrew M.;
    • Murdaugh, Donna L.;
    • Heinzman, Katherine A.;
    • Cardan, Rex A.;
    • Jacob, Jessica;
    • Fiveash, John B.;
    • Nabors, L. Burt;
    • Cooper, Courtney A.;
    • Hoyle, John M.;
    • Milner, Desmin;
    • Cardenas, Carlos E.
    Publication type:
    Article
    34
    35
    36

    Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 393, doi. 10.2967/jnumed.116.178434
    By:
    • Lodge, Martin A.;
    • Holdhoff, Matthias;
    • Leal, Jeffrey P.;
    • Bag, Asim K.;
    • Nabors, L. Burt;
    • Mintz, Akiva;
    • Lesser, Glenn J.;
    • Mankoff, David A.;
    • Desai, Arati S.;
    • Mountz, James M.;
    • Lieberman, Frank S.;
    • Fisher, Joy D.;
    • Desideri, Serena;
    • Xiaobu Ye;
    • Grossman, Stuart A.;
    • Schiff, David;
    • Wahl, Richard L.
    Publication type:
    Article
    37
    38
    39

    Mitochondrial DNA sequence variation and risk of meningioma.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 155, n. 3, p. 319, doi. 10.1007/s11060-021-03878-5
    By:
    • Samanic, Claudine M.;
    • Teer, Jamie K.;
    • Thompson, Zachary J.;
    • Creed, Jordan H.;
    • Mokhtari, Sepideh;
    • Fridley, Brooke L.;
    • Nabors, L. Burt;
    • Williams, Sion L.;
    • Egan, Kathleen M.
    Publication type:
    Article
    40

    Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 163, doi. 10.1007/s11060-018-2786-8
    By:
    • Happold, Caroline;
    • Gorlia, Thierry;
    • Nabors, L. Burt;
    • Erridge, Sara C.;
    • Reardon, David A.;
    • Hicking, Christine;
    • Picard, Martin;
    • Stupp, Roger;
    • Weller, Michael;
    • For the EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups
    Publication type:
    Article
    41

    Complementary therapy and survival in glioblastoma.

    Published in:
    Neuro-Oncology Practice, 2015, v. 2, n. 3, p. 122, doi. 10.1093/nop/npv008
    By:
    • Mulpur, Bhageeradh H.;
    • Burt Nabors, L.;
    • Thompson, Reid C.;
    • Olson, Jeffrey J.;
    • LaRocca, Renato V.;
    • Thompson, Zachary;
    • Egan, Kathleen M.
    Publication type:
    Article
    42
    43
    44

    A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses.

    Published in:
    Molecular Therapy, 2014, v. 22, n. 5, p. 1048, doi. 10.1038/mt.2014.22
    By:
    • Markert, James M;
    • Razdan, Shantanu N;
    • Kuo, Hui-Chien;
    • Cantor, Alan;
    • Knoll, Anette;
    • Karrasch, Matthias;
    • Nabors, L Burt;
    • Markiewicz, Michael;
    • Agee, Bonita S;
    • Coleman, Jennifer M;
    • Lakeman, Alfred D;
    • Palmer, Cheryl A;
    • Parker, Jacqueline N;
    • Whitley, Richard J;
    • Weichselbaum, Ralph R;
    • Fiveash, John B;
    • Gillespie, G Yancey
    Publication type:
    Article
    45

    A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

    Published in:
    Molecular Therapy, 2004, v. 10, n. 5, p. 958, doi. 10.1016/j.ymthe.2004.07.021
    By:
    • Chiocca, E. Antonio;
    • Abbed, Khalid M.;
    • Tatter, Stephen;
    • Louis, David N.;
    • Hochberg, Fred H.;
    • Barker, Fred;
    • Kracher, Jean;
    • Grossman, Stuart A.;
    • Fisher, Joy D.;
    • Carson, Kathryn;
    • Rosenblum, Mark;
    • Mikkelsen, Tom;
    • Olson, Jeff;
    • Markert, James;
    • Rosenfeld, Steven;
    • Nabors, L. Burt;
    • Brem, Steven;
    • Phuphanich, Surasak;
    • Freeman, Scott;
    • Kaplan, Rick
    Publication type:
    Article
    46